| 12337068 |
Lipid nanoparticle compositions and uses thereof |
Mirko Hennig, Ali Ahmed Alfaifi, Sakya Sing Mohapatra, Daniella Ishimaru, Vladimir Kharitonov +5 more |
2025-06-24 |
| 12257318 |
Polynucleotide compositions, related formulations, and methods of use thereof |
Mirko Hennig, Daniella Ishimaru, David J. Lockhart, Michael Torres, Jackson Eby +1 more |
2025-03-25 |
| 12133923 |
Lipid nanoparticle compositions and uses thereof |
Mirko Hennig, Ali Ahmed Alfaifi, Sakya Sing Mohapatra, Daniella Ishimaru, Vladimir Kharitonov +5 more |
2024-11-05 |
| 12121610 |
Compositions and methods for targeted delivery to cells |
Mirko Hennig, Vladimir Kharitonov, Jackson Eby, Rumpa Bhattacharjee |
2024-10-22 |
| 11786610 |
Treatment of primary ciliary dyskinesia with synthetic messenger RNA |
David J. Lockhart, Mirko Hennig, Daniella Ishimaru |
2023-10-17 |
| 11642421 |
Treatment of primary ciliary dyskinesia with synthetic messenger RNA |
David J. Lockhart, Mirko Hennig, Daniella Ishimaru |
2023-05-09 |
| 11510997 |
Treatment of primary ciliary dyskinesia with synthetic messenger RNA |
David J. Lockhart, Mirko Hennig, Daniella Ishimaru |
2022-11-29 |
| RE48608 |
Method to predict response to pharmacological chaperone treatment of diseases |
Elfrida Benjamin, Hung V. Do, John Flanagan, Xiaoyang Wu |
2021-06-29 |
| 10813921 |
Method to predict response to pharmacological chaperone treatment of diseases |
Elfrida Benjamin, Hung V. Do, Xiaoyang Wu, John Flanagan |
2020-10-27 |
| 10064851 |
Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase |
— |
2018-09-04 |
| 9931353 |
Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases |
Kenneth Valenzano, Robert Boyd |
2018-04-03 |
| 9675627 |
Dosing regimens for treating and/or preventing cerebral amyloidoses |
— |
2017-06-13 |
| 9597324 |
Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes |
— |
2017-03-21 |
| 9545397 |
Method to predict response to pharmacological chaperone treatment of diseases |
Elfrida Benjamin, Hung V. Do, Xiaoyang Wu, John Flanagan |
2017-01-17 |
| 9402837 |
Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase |
— |
2016-08-02 |
| 9119845 |
Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
— |
2015-09-01 |
| 9095584 |
Method to predict response to pharmacological chaperone treatment of diseases |
Elfrida Benjamin, Hung V. Do, Xiaoyang Wu, John Flanagan |
2015-08-04 |
| 9056101 |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
David J. Lockhart |
2015-06-16 |
| 9044437 |
Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases |
Kenneth Valenzano, Robert Boyd |
2015-06-02 |
| 8883813 |
Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes |
— |
2014-11-11 |
| 8592362 |
Method to predict response to pharmacological chaperone treatment of diseases |
Elfrida Benjamin, Hung V. Do, Xiaoyang Wu, John Flanagan |
2013-11-26 |
| 7964617 |
Methods for treating parkinsons disease and parkinsonism |
— |
2011-06-21 |
| 7829579 |
Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase |
— |
2010-11-09 |